By and Between
Gerald Vosika, M.D.
Agreement made as of this 1st day of June, 1996, between ImmunoTherapeutics, Inc., a Delaware corporation
(the "Company") and Gerald Vosika, M.D. (the "Executive").
The Executive is presently employed by the Company as Chairman of the Board, President and Scientific
The Board of Directors of the Company (the "Board") recognizes that the Executive's contribution to the
Company during the past years has been substantial. The Board desires to provide for the continued employment
of the Executive and to make certain changes in the Executive's employment arrangements with the Company
which the Board has determined will reinforce and encourage the continued attention and dedication to the
Company of the Executive as a member of the Company's management, in the best interest of the Company and
its shareholders. The Executive is willing to commit himself to continue to serve the Company, on the terms and
conditions herein provided.
In order to effect the foregoing, the Company and the Executive wish to enter into an employment agreement on
the terms and conditions set forth below. Accordingly, in consideration of the promises and the respective
covenants and agreements of the parties herein contained, and intending to be legally bound hereby, the parties
hereto agree as follows:
The Company hereby agrees to continue to employ the Executive, and the Executive hereby agrees to continue to
serve the Company, on the terms and conditions set forth herein.
The employment of the Executive by the Company as provided in Section 1 will commence on the date hereof
and end on May 31, 1999, unless further extended or sooner terminated as hereinafter provided. On and before
May 31, 1999, and on the last day of each year thereafter, the term of the Executive's employment shall be
automatically extended one (1) additional year unless, prior to such May 31 of such year, the Company sh